Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daiki Kayano

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Nuclear Medicine and Molecular Imaging|August 14, 2018
Current Consensus on I-131 MIBG TherapyDaiki Kayano, Seigo Kinuya
Thescientificworldjournal|April 16, 2015
Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspectiveDaiki Kayano, Seigo Kinuya
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 29, 2021
[Radiation Protection Against Exposure from Patients Receiving <sup>131</sup>I-MIBG and Released from Radiation Treatment Room]Anri Inaki, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|February 20, 2009
Gated myocardial perfusion SPECT for preoperative risk stratification in patients with noncardiac vascular diseaseDaiki Kayano, Kenichi Nakajima, Hiroshi Ohtake, et al.
Nuklearmedizin. Nuclear Medicine|June 7, 2022
I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paragangliomaXue Zhang, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|December 2, 2024
The 13th World Federation of Nuclear Medicine and Biology congress (WFNMB 2022): summarize the past half century and discuss the next half century of WFNMBHirofumi Fujii, Hiroshi Toyama, Daiki Kayano, et al.
Seminars in Nuclear Medicine|January 14, 2023
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and ParagangliomaXue Zhang, Hiroshi Wakabayashi, Tomo Hiromasa, et al.
Annals of Nuclear Medicine|April 18, 2021
Comparison of the detecting capability between <sup>123</sup>I-mIBG and post-therapeutic <sup>131</sup>I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapyZhong-Ling Qiu, Shintaro Saito, Daiki Kayano, et al.
Annals of Nuclear Medicine|October 14, 2006
Fluctuation of adenosine concentration by modes of intravenous infusion based on mathematical simulation and experimentsKenichi Nakajima, Junichi Taki, Tatsuya Yoneyama, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 12, 2025
[The 46th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 49th Survey in 2023)], Hidehiko Okazawa, Tomoya Uehara, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Nuclear Medicine and Molecular Imaging|August 14, 2018
Current Consensus on I-131 MIBG TherapyDaiki Kayano, Seigo Kinuya
Thescientificworldjournal|April 16, 2015
Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspectiveDaiki Kayano, Seigo Kinuya
Kaku Igaku. the Japanese Journal of Nuclear Medicine|July 29, 2021
[Radiation Protection Against Exposure from Patients Receiving <sup>131</sup>I-MIBG and Released from Radiation Treatment Room]Anri Inaki, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|February 20, 2009
Gated myocardial perfusion SPECT for preoperative risk stratification in patients with noncardiac vascular diseaseDaiki Kayano, Kenichi Nakajima, Hiroshi Ohtake, et al.
Nuklearmedizin. Nuclear Medicine|June 7, 2022
I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paragangliomaXue Zhang, Hiroshi Wakabayashi, Daiki Kayano, et al.
Annals of Nuclear Medicine|December 2, 2024
The 13th World Federation of Nuclear Medicine and Biology congress (WFNMB 2022): summarize the past half century and discuss the next half century of WFNMBHirofumi Fujii, Hiroshi Toyama, Daiki Kayano, et al.
Seminars in Nuclear Medicine|January 14, 2023
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and ParagangliomaXue Zhang, Hiroshi Wakabayashi, Tomo Hiromasa, et al.
Annals of Nuclear Medicine|April 18, 2021
Comparison of the detecting capability between <sup>123</sup>I-mIBG and post-therapeutic <sup>131</sup>I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapyZhong-Ling Qiu, Shintaro Saito, Daiki Kayano, et al.
Annals of Nuclear Medicine|October 14, 2006
Fluctuation of adenosine concentration by modes of intravenous infusion based on mathematical simulation and experimentsKenichi Nakajima, Junichi Taki, Tatsuya Yoneyama, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|February 12, 2025
[The 46th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 49th Survey in 2023)], Hidehiko Okazawa, Tomoya Uehara, et al.
Pageof 4